Symptoms and General Pathology

All Conditions

Nervous System Diseases

Rare Diseases

Chronic Pain

Cancer Pain

Pain

Neurologic Manifestations

Chronic Graft Versus Host Disease

Analgesics

Central Nervous System Depressants

All Drugs and Chemicals

Analgesics, Opioid

Patients in this Pilot Cohort will be in the research study for 6 weeks total including:

* a 4-week intervention period and 2-week post intervention period.
* Patients will use the app for a total of 4 weeks (4-week intervention period), and will complete surveys at baseline, 4 weeks (end of intervention period), and at 6 weeks (end of 2-week post intervention period).

Use the STAMP+CBT mobile app for 4 weeks (intervention period, 4 weeks for content introduction, extended 2 weeks for review of content if patient's request this

STAMP+CBT application

Desiree Azizoddin, PsyD

Desiree R Azizoddin, PsyD

Frederick Briccetti, MD

Pedro Sanz-Altamira, MD

The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.

This research study involves the use of a smartphone app at home in addition to surveys and potentially an interview at the end of the study.

The research study procedures include screening for eligibility, study interventions include surveys at the beginning of the study, after 4 weeks, and after 6 weeks and use of the smartphone app.

Participants will be on this research study for up to 6 weeks.

It is expected that about 15 people will take part in this research study

This research study is a Feasibility Study, which is the first-time investigators are examining this mobile application meant to help participant to learn behavioral techniques to manage cancer pain. The purpose is to make sure the app is usable and helpful for patients with cancer, and to get feedback about patient experiences after using the app for four weeks.

STAMP+CBT mHealth for Cancer Pain

Harnessing Mobile Technology to Deliver Tailored, Brief Pain-CBT for Advanced Cancer Patients on Opioids for Pain

The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to Sponsor Investigator or designee. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research

\>70% of subjects complete \>4 of the 6 pain-CBT modules and patients will complete 60% of surveys by the end of 4 weeks (completion of the 4-week intervention study period)(completion of the 4-week intervention study period)

\>80% of the acceptability items are rated 4 or higher/5; lower ratings will lead to app refinements

15 patients will be enrolled to the trial within 6 months

60% of patients who enroll to the app with complete app use at the end of the 4 weeks and surveys at 4 and 6 weeks after enrollment

Overall acceptability will be determined based on composite evaluation of acceptability ratings using the e-Acceptability scale, app content completion rates, and qualitative patient feedback.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
STAMP+CBT mHealth for Cancer Pain	NCT05403801	Active Cancer Active Cancer T... Advanced Cancer Palliative Care Chronic Pain Du...	STAMP+CBT appli...	18 Years -	Dana-Farber Cancer Institute
STAMP+CBT mHealth for Cancer Pain	NCT05403801	Active Cancer Active Cancer T... Advanced Cancer Palliative Care Chronic Pain Du...	STAMP+CBT appli...	18 Years -	Dana-Farber Cancer Institute
STAMP+CBT mHealth for Cancer Pain	NCT05403801	Active Cancer Active Cancer T... Advanced Cancer Palliative Care Chronic Pain Du...	STAMP+CBT appli...	18 Years -	Dana-Farber Cancer Institute

Spots Global Cancer Trial Database for active cancer treatment